Search - tctmd.com

Displaying 41 - 60 of 116

Sort: Relevancy | Date

News Daily News

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Michael O'Riordan

June 02, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Conference News AHA 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

Shelley Wood

November 18, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Michael O'Riordan

November 13, 2019

News Daily News

Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release

Michael O'Riordan

November 11, 2019

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Michael O'Riordan

October 22, 2019

Advertisement

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Experts Fear Coronary CT Advice for Patients Misses the Mark

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content